CTC
BIIB icon

Central Trust Company’s Biogen BIIB Stock Holding History

Central Trust Company’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.9K Hold
163
– – ﹤0.01% 941
2025
Q4 		$28.7K Hold
163
– – ﹤0.01% 914
2025
Q3 		$22.8K Hold
163
– – ﹤0.01% 955
2025
Q2 		$20.5K Sell
163
-40
-20% -$4.98K ﹤0.01% 976
2025
Q1 		$27.8K Buy
203
+30
+17% +$4.29K ﹤0.01% 916
2024
Q4 		$26.5K Sell
173
-60
-26% -$10.1K ﹤0.01% 916
2024
Q3 		$45.2K Sell
233
-3
-1% -$628 ﹤0.01% 805
2024
Q2 		$54.7K Buy
236
+3
+1% +$652 ﹤0.01% 762
2024
Q1 		$50.2K Hold
233
– – ﹤0.01% 810
2023
Q4 		$60.3K Hold
233
– – ﹤0.01% 763
2023
Q3 		$59.9K Sell
233
-405
-63% -$108K ﹤0.01% 741
2023
Q2 		$182K Hold
638
– – 0.01% 563
2023
Q1 		$177K Buy
638
+245
+62% +$67.8K 0.01% 560
2022
Q4 		$109K Sell
393
-200
-34% -$56.5K ﹤0.01% 631
2022
Q3 		$158K Sell
593
-25
-4% -$5.31K 0.01% 564
2022
Q2 		$126K Hold
618
– – ﹤0.01% 601
2022
Q1 		$130K Sell
618
-20
-3% -$4.35K ﹤0.01% 638
2021
Q4 		$153K Sell
638
-175
-22% -$45K ﹤0.01% 616
2021
Q3 		$230K Sell
813
-26
-3% -$8.52K 0.01% 524
2021
Q2 		$291K Sell
839
-110
-12% -$33.3K 0.01% 477
2021
Q1 		$265K Buy
949
+110
+13% +$29.7K 0.01% 469
2020
Q4 		$205K Hold
839
– – 0.01% 474
2020
Q3 		$238K Buy
839
+14
+2% +$3.9K 0.01% 430
2020
Q2 		$221K Sell
825
-45
-5% -$13.5K 0.01% 426
2020
Q1 		$275K Sell
870
-5
-0.6% -$1.52K 0.02% 374
2019
Q4 		$260K Hold
875
– – 0.01% 419
2019
Q3 		$204K Sell
875
-549
-39% -$128K 0.01% 438
2019
Q2 		$330K Sell
1,424
-2,980
-68% -$688K 0.02% 381
2019
Q1 		$1.04M Sell
4,404
-149
-3% -$46.9K 0.06% 226
2018
Q4 		$1.37M Buy
4,553
+150
+3% +$47.9K 0.09% 189
2018
Q3 		$1.55M Buy
4,403
+5
+0.1% +$1.72K 0.09% 190
2018
Q2 		$1.28M Sell
4,398
-157
-3% -$44.1K 0.08% 208
2018
Q1 		$1.25M Buy
4,555
+32
+0.7% +$9.93K 0.08% 210
2017
Q4 		$1.44M Buy
4,523
+116
+3% +$37.2K 0.09% 197
2017
Q3 		$1.38M Buy
4,407
+55
+1% +$16.3K 0.09% 196
2017
Q2 		$1.18M Buy
4,352
+1,050
+32% +$278K 0.08% 211
2017
Q1 		$903K Sell
3,302
-630
-16% -$178K 0.06% 238
2016
Q4 		$1.11M Sell
3,932
-3,351
-46% -$993K 0.08% 210
2016
Q3 		$2.28M Buy
7,283
+4,737
+186% +$1.4M 0.17% 140
2016
Q2 		$616K Sell
2,546
-194
-7% -$51.1K 0.05% 275
2016
Q1 		$713K Buy
2,740
+576
+27% +$152K 0.06% 250
2015
Q4 		$663K Buy
2,164
+414
+24% +$119K 0.05% 249
2015
Q3 		$511K Sell
1,750
-9,333
-84% -$3.08M 0.04% 278
2015
Q2 		$4.48M Sell
11,083
-827
-7% -$332K 0.35% 74
2015
Q1 		$5.03M Buy
11,910
+3,408
+40% +$1.34M 0.4% 64
2014
Q4 		$2.89M Sell
8,502
-566
-6% -$183K 0.24% 109
2014
Q3 		$3M Sell
9,068
-127
-1% -$41.9K 0.24% 105
2014
Q2 		$2.9M Sell
9,195
-52
-0.6% -$15.7K 0.23% 107
2014
Q1 		$2.83M Buy
9,247
+415
+5% +$132K 0.23% 105
2013
Q4 		$2.47M Buy
8,832
+1,654
+23% +$428K 0.21% 116
2013
Q3 		$1.73M Buy
7,178
+66
+0.9% +$14.8K 0.16% 137
2013
Q2 		$1.53M Buy
+7,112
New +$1.52M 0.15% 144

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Central Trust Company's BIIB Position: Q1 2026 in Review

Central Trust Company held its Biogen (BIIB) position steady in Q1 2026 at 163 shares worth $29.9K. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Central Trust Company first reported a position in BIIB in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.03M in Q1 2015. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Central Trust Company held 163 shares of Biogen worth $29.9K as of Q1 2026.
  • Central Trust Company left its Biogen share count unchanged in Q1 2026.
  • Biogen made up ﹤0.01% of Central Trust Company's portfolio in Q1 2026, its #941 holding.
  • Central Trust Company first reported a position in Biogen in Q2 2013 and has held it in 52 quarters since.
  • Central Trust Company's Biogen position peaked at $5.03M in Q1 2015.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Central Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.